GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Strategic Ventures (OTCPK:NUGS) » Definitions » 10-Year RORE %

Cannabis Strategic Ventures (Cannabis Strategic Ventures) 10-Year RORE % : 0.00% (As of Jun. 2020)


View and export this data going back to 2005. Start your Free Trial

What is Cannabis Strategic Ventures 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Cannabis Strategic Ventures does not have enough data to calculate 10-Year RORE %.


Cannabis Strategic Ventures 10-Year RORE % Historical Data

The historical data trend for Cannabis Strategic Ventures's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Strategic Ventures 10-Year RORE % Chart

Cannabis Strategic Ventures Annual Data
Trend Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20
10-Year RORE %
Get a 7-Day Free Trial - - - - -

Cannabis Strategic Ventures Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cannabis Strategic Ventures's 10-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Strategic Ventures's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Strategic Ventures's 10-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Strategic Ventures's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Cannabis Strategic Ventures's 10-Year RORE % falls into.



Cannabis Strategic Ventures 10-Year RORE % Calculation

Cannabis Strategic Ventures's 10-Year RORE % for the quarter that ended in Jun. 2020 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( - )
=/
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2020 and 10-year before.


Cannabis Strategic Ventures  (OTCPK:NUGS) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Cannabis Strategic Ventures 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Cannabis Strategic Ventures's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Strategic Ventures (Cannabis Strategic Ventures) Business Description

Traded in Other Exchanges
N/A
Address
9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212
Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.
Executives
Gordon Samson director, officer: Chief Financial Officer 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Dane Brown director, officer: VP, Corporate Development 9595 WILSHIRE BOULEVARD, SUITE 900 BEVERLY HILLS CA 90212
Christopher G Foster director, officer: CFO, Secretary & Treasurer 5151 E. BROADWAY, SUITE 1600, TUCSON AZ 85711
Robert Hoegler director, 10 percent owner, officer: President #604 7040 GRANVILLE AVENUE RICHMOND A1 V6Y 3W5
Floyd Flaman director, 10 percent owner, officer: SECRETARY/TREASURER 5621 52ND STREET DELTA A1 V4K 2C7
Scott Marshall director, 10 percent owner, officer: President 2435 WEST 7TH AVENUE VANCOUVER A1 00000

Cannabis Strategic Ventures (Cannabis Strategic Ventures) Headlines